Advertisement

Topics

Chugai Pharma Europe Limited Company Profile

04:07 EDT 25th September 2017 | BioPortfolio

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Location

United Kingdom


News Articles [2678 Associated News Articles listed on BioPortfolio]

Tokyo drift? Large molecule R&D shortfall threat to Japanese pharma, says Chugai

A failure to embrace biologics R&D has restricted Japanese pharma’s global growth, says CEO of Roche subsidiary Chugai Pharmaceuticals.

Arbitration against Chugai commenced

Japanese drug major Chugai Pharmaceutical today announced that an arbitration against Chugai has been…

Roche and Chugai Pharma report positive Phase III results of haemophilia A drug

Roche and UK-based Chugai Pharmaceutical have reported positive data from the Phase III HAVEN 1 clinical trial of emicizumab in patients suffering from haemophilia A.

Chugai Pharma phase III IMvigor211 study in patients with locally advanced/mUC fails to meet primary endpoint

Chugai Pharmaceutical announced that atezolizumab did not meet its primary endpoint of statistically meaningful improvement in overall survival (OS) compared to chemotherapy in the phase III IMvigor21...

Chugai's Emicizumab Receives Priority Review Designation by FDA for Hemophilia A with Inhibitors

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the US Food and Drugs Administration (FDA) has accepted the Biologics License Application (BLA) and has gr...

Chugai files lawsuit to protect its Herceptin

Japan’s Chugai Pharmaceutical saw its shares gain 2.15% to 4,515 yen, after it revealed legislation…

Chugai says it is being sued for patent infringement by Baxalta

Japanese drug major Chugai Pharmaceutical says that a lawsuit was filed against the company at the US…

Results Of The J-ALEX Study For Chugai Pharma's Alecensa Are Published In "The Lancet" Online

  Life Sciences Jobs   ...

PubMed Articles [440 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

E-WIN Project 2016: Evaluating the current gender situation in neurosurgery across Europe. An interactive, multiple-level Survey.

The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...

Clinical Trials [569 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

THE STUDY WILL BE A TWO-PART RESEARCH PART A and PART A extended: 1. To implement a "common" MRI acquisition protocol in multiple centers across Europe (Pharma-COG partners)...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1579 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Chugai Pharma Europe Limited" on BioPortfolio

We have published hundreds of Chugai Pharma Europe Limited news stories on BioPortfolio along with dozens of Chugai Pharma Europe Limited Clinical Trials and PubMed Articles about Chugai Pharma Europe Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharma Europe Limited Companies in our database. You can also find out about relevant Chugai Pharma Europe Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record